Literature DB >> 18640437

Will anti-amyloid therapies work for Alzheimer's disease?

Peter H St George-Hyslop1, John C Morris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18640437     DOI： 10.1016/S0140-6736(08)61047-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  28 in total

1.  Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Joshua D Grill; Lijie Di; Po H Lu; Cathy Lee; John Ringman; Liana G Apostolova; Nicole Chow; Omid Kohannim; Jeffrey L Cummings; Paul M Thompson; David Elashoff
Journal:  Neurobiol Aging       Date:  2012-04-13       Impact factor: 4.673

2.  Extracting β-amyloid from Alzheimer's disease.

Authors:  Daniel R Dries; Gang Yu; Joachim Herz
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-10       Impact factor: 11.205

Review 3.  Current therapeutic targets for the treatment of Alzheimer's disease.

Authors:  Joshua D Grill; Jeffrey L Cummings
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

4.  Sub-millimeter isotropic MRI for segmentation of subcortical brain regions and brain visualization.

Authors:  Ying Wu; Ann B Ragin; Hongyan Du; Shawn Sidharthan; Eugene E Dunkle; Ioannis Koktzoglou; Robert R Edelman
Journal:  J Magn Reson Imaging       Date:  2010-04       Impact factor: 4.813

5.  Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease.

Authors:  Randy L Buckner; Jorge Sepulcre; Tanveer Talukdar; Fenna M Krienen; Hesheng Liu; Trey Hedden; Jessica R Andrews-Hanna; Reisa A Sperling; Keith A Johnson
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

6.  [Innovative treatment approaches for Alzheimer's disease. Immunotherapy].

Authors:  R Dodel; M Bacher
Journal:  Nervenarzt       Date:  2008-11       Impact factor: 1.214

7.  Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component.

Authors:  Simon E Kolstoe; Basil H Ridha; Vittorio Bellotti; Nan Wang; Carol V Robinson; Sebastian J Crutch; Geoffrey Keir; Riitta Kukkastenvehmas; J Ruth Gallimore; Winston L Hutchinson; Philip N Hawkins; Stephen P Wood; Martin N Rossor; Mark B Pepys
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-16       Impact factor: 11.205

Review 8.  Why pleiotropic interventions are needed for Alzheimer's disease.

Authors:  Sally A Frautschy; Greg M Cole
Journal:  Mol Neurobiol       Date:  2010-05-02       Impact factor: 5.590

Review 9.  Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo.

Authors:  G D Rabinovici; W J Jagust
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

Review 10.  Alternative Abeta immunotherapy approaches for Alzheimer's disease.

Authors:  Terrence Town
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-04       Impact factor: 4.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.